Hrvatske vode
 
Farmaceutici i metode obrade otpadne vode iz farmaceutske industrije
Pharmaceuticals and methods of treating wastewater from pharmaceutical industry

Stanka Zrnčević1

Sažetak/Abstract: 

Potrošnja farmaceutika za humanu i veterinarsku primjenu u uzlaznoj je putanji, kao i njihovo otpuštanje u okoliš. Farmaceutici su nađeni u ispustima nakon obrade otpadnih voda, površinskim vodama, tlu i vodovodnoj vodi. Premda su te koncentracije općenito niske, raste zabrinutost zbog mogućeg dugoročnog utjecaja na ljude i vodene organizme uslijed trajne izloženosti ovim spojevima. Zbrinjavanje takvih voda vrlo je specifično i složeno te redovito zahtijeva kombinaciju različitih postupaka obrade kako bi se ove vode učinile neškodljive te zadovoljili propisani zakonski kriteriji za ispust u okoliš.

U radu su navedeni izvori te mogući štetni utjecaji farmaceutika na okoliš. Dani su podatci o sastavu otpadnih voda nastalih u proizvodnji farmaceutika kemijskom sintezom te su naznačena mjesta u procesu na kojima nastaju. Dan je literaturni pregled konvencionalnih i naprednih metoda obrade te su navedene njihove prednosti i nedostatci.

 

The consumption of pharmaceuticals for human and veterinary uses shows an upward trend, as well as their release into the environment. Pharmaceuticals are found in discharges after wastewater treatment, in surface waters, soil and tap water. Although these concentrations are generally low, there is a growing concern about the possible long-term effects on humans and aquatic organisms due to a prolonged exposure to these compounds. The treatment of such water is very specific and complex, and regularly requires a combination of different treatment methods to render such water harmless and fulfil the legislative criteria for discharges into the environment.

The paper lists the sources and potential adverse effects of pharmaceuticals on the environment and includes data about the composition of wastewater generated in the production of pharmaceuticals in the process of chemical synthesis, with indications of exact phases in the process when they are generated. An overview of conventional and advanced treatment methods, including their advantages and shortcomings, is also provided.

Kategorija: 
Pregledni članak / Review Paper
Ključne riječi/Key words: 

farmaceutici, mikrozagađivala, otpadne vode, procesi obrade

pharmaceuticals,micropollutants,wastewater,treatment processes

Podaci o autorima/Authors affiliations: 

1Sveučilište u Zagrebu, Fakultet kemijskog inženjerstva i tehnologije, Marulićev trg 19, 10000 Zagreb szrnce@fkit.hr

Literatura/References: 

Abd El-Gawad H.A.; Aly M.A. (2011.):Assessment of aquatic environmental for wastewater management quality in the hospitals: a case study. Australian Journal of Basic and Applied Sciences, 5, 474-782.

 

Abou-Elala S.I.; Abou Taleb E.; Ali M.; Badar NN.; Abdel Halim W. Environmental management of pharmaceutical wastes: Experience from Egypt. Sixteenth International Water Technology Conference (IWTC 16, 2012), May 7-10, 2012, Istanbul, Turkey, pp.1-11.

 

Adishkumar S.; Kanmani, S. (2010.): Treatment of phenolic wastewatersin single baffle reactor by solar/TiO2/H2O2 process. Desalination WaterTreatment,24, 67−73.

 

Alaton I. A.; Dogruel S.; Baykal E.; Gerone G. (2004.): Combined chemical and biological oxidation of penicillin formulation effluent. Journal of Environmental Management, 73, 155−163.

 

Al-BahryS.N.; MahmoudI.Y.; PaulsonJ.R.; Al-Musharafi S.K. (2014.): Survival and growth of antibiotic resistant bacteria in treated wastewater and water distribution system and their implication in human health: A review.The International Arabic Journal of Anti microbial Agents, 4, 2-11.

 

Allen H.K.; Donato J.; Wang H.H.; Cloud-Hansen K.A.; Davies J.; Handelsman J. (2010.): Call of the wild: antibiotic resistance genes in natural environments. Nature Reviews Microbiology,8, 251-259.

 

Andreozzi, R.; Caprio, V.; Insola, A.; Marotta, R. (1999.): Advanced oxidation processes (AOP) for water purification and recovery.Catalysis Today, 53, 51-59.

 

Ali I.; Al-Hashimi, M.; Hadi Abbas, A. (2007.): Sequential anaerobic/aerobic treatment of pharmaceutical wastewater.Tikrit Journal of Engineering Sciences, 14, 1-29.

 

A.P. Pollution Control Board, Hyderabad. (1999.): Opportunities for waste minimization in bulk drug and dye intermediate industries. APPCB Information Bulletin, Publication 105, 1-4.

 

Arslan-alton I.; Dogruel S. (2004.): Pre-treatment of penicillin formulation effluent by advanced oxidation processes, Journal of Hazardous Materials, 112, 105-113.

 

Babu B.R.; Venkatesan P.; Kanimozhi R.; Basha C.A. (2009.): Removal of pharmaceuticals from wastewater by electrochemical oxidation using cylindrical flow reactor and optimization of treatment conditions. Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances & Environmental Engineering, 44, 985-994.

 

Badawy M.I.; Wahaab, R.A. (2009.): Fenton-biological treatment processes for the removal of some pharmaceuticals from industrial wastewater. Journal of Hazardous Materials, 167, 567-574.

 

Balcioglu I.A.; Otker M. (2003.): Treatment of pharmaceutical wastewater containing antibiotics by O3 and O3/H2O2 processes. Chemosphere, 50, 85-95.

 

Baydum V. P. A.; Dantas R. F.; Teixeira A.; Pacheco J. G. A.; Silva V. L. (2012.): Pre-treatment of propranololef fluent by advanced oxidation processes.Afinidad, 69, 211-216.

 

Behera S.K.; Kim H.W; Oh J-E.; Park H-S. (2011.): Occurrence and removal of antibiotics, hormones and several other pharmaceuticals in wastewater treatment plants of the largest industrial city of Korea.

 

Science of the Total Environment, 409, 4351-4360. Boehler M.; Zwickenpflug B.; Hollender J.; Ternes T.; Joss A.; Siegrist H. (2012.): Removal ofmicropollutants in municipal wastewater treatment plants by powderactivated carbon. Water Science & Technology, 66, 2115-2121.

 

Boroski M.; Rodrigues A. C.; Garcia J. C.; Sampaio L. C.; Nozaki J.; Hioka N. (2009.): Combined electrocoagulation and TiO2 photoassisted treatment applied to wastewater effluents from pharmaceutical and cosmetic industries. Journal of Hazardous Materials,162, 448−454.

 

Brillas E.; Sirés I.; Oturan M. A. (2009.): Electro-fenton process and related electrochemical technologies based on Fenton s reaction chemistry. Chemical Reviews, 109, 6570-6631.

 

Brillas E.; Garcia-Segura S.; Skoumal M.; Arias C. (2010.): Electrochemical incineration of diclofenac in neutral aqueous medium by anodic oxidation using Pt and borondoped diamond anodes.Chemosphere, 79, 605−612.

 

Camacho-Muñoz D.; Martín J.; Santos J.L.; Aparicio I.; Alonso E. (2012.): Effectiveness of conventional and low-cost wastewater treatments in the removal of pharmaceutically active compounds. Water,Air&Soil Pollution, 223, 2611-2621.

 

Carballa M.; Fink G.; Omil F.; Lema J.; Ternes T. (2008.): Determination of solid-water distribution coefficient (KD) for pharmaceutical, estrogens and muskfragrances in digested sludge. Water Research, 42, 287-295.

 

Carter L.J.; Harris E.; Williams M.; Ryan J.J.; Kookana R.S.; Boxall A.B.A. (2014.): Fate and uptake of pharmaceuticals in soil plant systems. Journal of Agricultural and Food Chemistry, 62, 816-825.

 

Chang C.Y.; Chang J.S.; Vigneswaran S.; Kandasamy J. (2008.): Pharmaceutical wastewater treatment by membrane bioreactor process-A case study in southern Taiwan. Desalination, 234, 393–401.

 

Chaudhuri M.; Wahap M.Z.B.A.; Affam A.C. (2013.): Treatment of aqueous solution of antibiotics amoxicillin and cloxacillin by modified Photo-fenton process. Desalination and Water Treatment, 51, 37-39.

 

Chelliapan S.; Wilby T.; Sallis P.J. (2011.b). Effect of hydraulic retention time on up-flow anaerobic stage reactor performance at constant loading in the presence of antibiotic tylosin. Brazilian Journal of Chemical Engineering, 28, 51-61.

 

Chen Z.; Ren N.; Wang A.; Zhang Z.; Shi Y.A. (2008.): A novel application of TPAD-MBR system to the pilot treatment of chemical synthesis-based pharmaceutical wastewater. Water Research, 42, 3385-3392.

 

Chong M.N.; Jin, B. (2012.): Photocatalytic treatment of high concentration carbamazepine in synthetic hospital wastewater. Journal of Hazardous Materials, 199-200, 135-142

 

Clara M.; Strenn B.; Gans O.; Martinez E.; Kreuzinger N.; Kroiss H. (2005.): Removal of selected pharmaceuticals, fragrance and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Research, 39, 4797-4807.

 

Cyr P.J.; Suri R.P.; Helmig E.D.(2002.): A pilot scale evaluation of removal of mercury from pharmaceutical wastewater using granular activated carbon. Water Research. 36, 4725-4734.

 

Dai Q.; Xia Y.; Jiang L.; Li X.; Wang J.; Chen J. (2012.): Enhanced degradation of aspirin by electrochemical oxidation with modified PbO2 electrode and hydrogen peroxide. International Journal of Electrochemical Science, 7, 12895 – 12906.

 

Deegan A.M.; Shaik B.; Nolan K.; Urell K.; Oelgemöller M.; Tobin J.; Morrissey A. (2011.): Treatment options for wastewater effluents from pharmaceutical companies. International Journal of Environmental Science&Technology, 8, 649-666.

 

De Gunzburg J.; Bensoussan C. Methods for the inactivation of antibiotic. WO 2012007536 A1, 19.siječanja 2012.

 

De la Cruz N.; Giménez J.; Esplugas S.; Grandjean, de Alencastro L.F.; Pulgarín C. (2012.): Degradationof 32 emergent contaminants by UV and neutral photofenton in domestic wastewater effluent previously treated by activated sludge. Water Research, 46, 1947-1957.

 

Demarche p., Junghanns C.; Nair R.R. Agathos S.N. (2012.): Hernessing the power of enzymes for environmental stewardship. Biotechnology Advances, 30, 933-953.

 

Deshpande A.M.; Satyanarayan S. (2011.): Toxicity evaluation of through fish bioassay raw drug industrry wastewater after electrochemical treatment. Iran Journal of Environmental Health Science& Engineering,

8, 373-380.

Dolar D.; Košutić K.; Ignjatić Zokić T.; Sipos L.; Markić M.; Župan M. (2013.): Pharmaceutical wastewater treatment_A case study of high recovery. Polish Journal of Environmental Science, 6, 1677-1683.

 

Domínguez J. R..; González, T.; Palo P. (2012.): Electrochemical degradation of a real pharmaceutical effluent. Water, Air&Soil Pollution, 223, 2685−2694.

 

Elmola E.S.; Ramdass N.; Chaudhuri M. (2012.): Optimization ofsequencing batch reactor operating conditions for treatment of high-strength pharmaceutical wastewater.Journal of Environmental Science and Technology, 1-8.

 

Emmanuel E.; Perrodin Y.; Keck G.; Blanchard J. M.; Vermande P. (2005.): Ecotoxicological risk assessment of hospital wastewater: a proposed framework for raw effluents discharging into urban sewer network. Journal of Hazardous Material A.117, 1-11.

 

EPA (1997.): Profile of the pharmaceutical manufacturing industry, Office of Compliance Sector Notebook Project.

 

Fayyad M.; Ahmad, J. (2008.):Evaluation of biokinetic parameters for pharmaceutical wastewater using aerobic oxidation. Dirasat, Engineering Sciences, 35, 17-24.

 

Gadipelly C.; Pérez-González A.; Yadav G.D.; Ortiz I.; Ibáñ ez R.; Rathod V.K.; Marathe K.V. (2014.) Pharmaceutical industry wastewater: Review of the technologiesfor water treatment and reuse. Industrial & Engineering Chemistry Research.53, 11571−11592.

 

Galdos M.V.; De Maria I.C.; Otávio Antonio De Camargo O.A.; Dechen S.C.F. (2009.): Sewage sludge application on cultivated soils: effects on runoff and trace metal load. Scientia Agricola, 66, 368-376.

 

Garcia N.; Moreno J.; Cartmell E.; Rodriguez-Roda I.; Judd S. (2013.): The application of microfiltration -reverse osmosis/nanofiltration to trace organics removal for municipal wastewater reuse. Environmental Technology, 34, 3183-3189.

 

Gerrity D.; Gamage S.; Holady J.C.; Mawhinney D.B.; Quinones O.; Trenholm R.A.; Snyder S.A.(2011.): Pilotscale evaluation of ozone and biological activated carbon for trace organic contaminant mitigation and disinfection. Water Research, 45, 2155-2165.

 

Gogate P.R.; Pandit A.B. (2004.): A review of imperative technologies for wastewater treatmentI. Oxidation technologies at ambient conditions. Advances in Environmental Research, 8, 501-551.

 

Gome A.; Upadhyay K. (2013.) Biodegrability assessment of pharmaceutical wastewater treated by ozone. International Research Journal of Environmental Sciences, 2, 21-25.

 

Green R.E.; NewtonI., Shultz S.; Cunningham A.A.; Gilbert M.; Pain D.J.; Prakash V. (2004.): Diclofenac poisoning as a cause of vulture population declines across the Indian subcontinent. Journal of Applied Ecology, 41, 793–800.

 

Gros M.; Petrović M.; Barceló D. (2007.): Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the Ebro river basin (Northeast Spain). Environmental Toxicology and Chemistry, 26, 1553–1562.

 

Grover D.P.; Zhou J.L.; Frickers P.E.; Readman J.W. (2011.): Improved removal of estrogenic andpharmaceutical compounds in sewage effluent by full scale granular activated carbon: Impact on receiving river water. Journal of Hazardous Material, 185, 1005-1011.

 

Hathi S.R; Patel R. (2015.):Advanced treatment of treated pharmaceutical effluent with TiO2/H2O2.International Journal of Advance Research in Engineering, Science & Technology, 2, 1-4.

 

Heberer T.; Feldmann D. (2005.): Contribution of effluents from hospitals and private households to the total loads of dicofenac and carbamazepine in municipal sewage effluents-modelling versus measurements. Journal of Hazardous Material, 122, 211-218.

 

Hernández-Leal L.; Temmink H.; Zeeman G.; Buisman C.J.N. (2011.): Removal of micropollutants from aerobically treated grey water via ozone and activated carbon. Water Research, 45, 2887-2896.

 

Holm J.V; Rüge, K.; Bjerg P.L.; Christensen T.H. (1995.): Occurrence and distribution of pharmaceutical organic compounds in the groundwater downgradient of a landfill. Environmental Science and Technology, 29, 1415-1420.

 

Idris M.A.; Kolo B.G.; Garba S.T.; Ismail M.A. (2013.): Physico-chemical analysis of pharmaceutical effluent and surface water of river Gorax in Minna, Niger State, Nigeria. Bulletin of Environmental Pharmacology Life Sciences, 2, 45-49.

 

IWW-Rheinisch-Westfaelisches Institut für Wasser. (2014.): Pharmaceuticals in the environment – the global perspective: Occurrence, effects, and potential cooperative action under SAICM.

 

James S.L.; Adams C.J.; Bolm C.; Braga D.; Collier P.; Friščić T.; Grepioni P.; Harris K.D.M.; Hyett G.; Jones W.; Krebs A.; Mack J.; Maini L.; Orpen A.G.; Parkin I.P.; Shearouse W.C.; Steed J.W.; Waddell D.C. (2012.): Mechanochemistry: opportunities for new and cleaner synthesis.Chemical Society Reviews, 41 (2012) 413–447.

 

Jermann D.; Pronk W.; Boller M.; Schäfer A.I. (2009.): The role of NOM fouling for the retention ofestradiol and ibuprofen during ultrafiltration. Journal of Membrane Science, 329, 75-84.

 

Jobling S.; Nolan M.; Tyler C.R.; Brighty G.; Sumpter J.P. (1998.): Widespread sexual disruption in wild fish. Environmental Science &Technology, 32, 2498–2506.

 

Joss A.; Keller E.; Alder AC.; Göbel A.; McArdell CS.; Ternes T:; Siegrist H. (2005.): Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Research, 39, 3139-3152.

 

Kang J.; Zhan W.; Li D.; Wang X.; Song J.; Liu D. (2011.): Integrrated catalystic wet air oxidation and biologic treatment of wastewater from vitamin B6 production. Physicsand Chemistry of the Earth, 36, 455-458.

 

Kavitha R.V.; Krishna Murthy V.; Makam R.; Asith K. A. (2012.): Phisico-chemical analysis of effluents from pharmaceutical industry and its efficiency study. International Journal of Engineering Research and

Applications, 2, 103-110.

 

Karunya S.; Feroz S.; Al Harassi S.; Kishore S. (2015.): Treatment of Oman pharmaceutical industry wastewater using low cost adsorbents.Journal of Multidisciplinary Engineering Science and Technology, 2, 339-341.

 

Kim I.; Yamashita N.; Tanaka H. (2009.): Performance of UV and UV/H2O2 processes for the removal of pharmaceuticals detected in secondary effluent of a sewage treatment plant in Japan. Journal of Hazardous Materials, 166, 1134-1140.

 

Kim I.; Tanaka H. (2010.): Use of ozone-based processes for the removal of pharmaceuticals detected in a wastewater treatment plant.Water Environment Research, 82, 294-301.

 

Kim K.H.; Ihm S.K. (2011.): Heterogeneous catalytic wet air oxidation of refractory organic pollutants in industrial wastewater: A review. Journal of Hazardous Materials, 186, 16-34.

 

Körbahti B.K.; Tanyolaç, A. (2003.): Continuous electrochemical treatment of phenolic wastewater in a tubular reactor. Water Research, 37, 1505-1514.

 

KoyuncuI., Arikan O.A.; Wiesner M.R.; Rice C. (2008.): Removal of hormones and antibiotics by nanofiltration membranes, Journal of Membrane Science, 309, 94–101.

 

Košutić K.; Dolar D.; Ašperger D.; Kunst B. (2007.) Removal of antibiotics from a model wastewater by RO/NF membranes, Separation and Purification Technology, 53, 244–249.

 

Kovalova L.; Siegrist H.; Singer H.; Wittmer A.; McArdell C.S. (2012.): Hospital wastewater treatment by membrane bioreactor: performance and efficiency for organic micropollutant elimination. Environmental Science& Technology, 46,1536-1545.

 

Kovalova L.; Siegrist H.; von Gunten U.; Eugster J.; Hagenbuch M.; Wittmer A; Abegglen C.; Thonney D.; Chèvre N., Schärer M.; Barry D.A. (2013.):Elimination of micropollutants during post-treatment of hospital wastewater with powdered activated carbon, ozone, and UV. Environmental Science & Technology, 47, 7899-7808.

 

Kümmerer K. (2010.): Pharmaceuticals in the environment. Annual Review of Environment and Resources, 35, 57-75.

 

Larsson D.G.J. (2014.): Pollution from drug manufacturing: Review and perspectives. Philosophical Transactions of the Royal SocietiB, 369, 1-7.

 

Lokhande R.S.; Singare P.U.; Pimple D.S. (2011.): Toxicity study of heavy metals pollutants in wastewater

effluents samples collected from Taloja Industrial Estate of Mumbai, India. Resources and Environment, 1, 13-19.

 

Luo Y.; Guo W.; Ngo H. Hao.; Nghiem L.; Duc, Hai F.; Ibney, Zhang J.; Liang, S. (2014.): A review on the occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater treatment. Science of the Total Environment, 473-474, 619-641.

 

Madukasi E.I.; Dai X.; He C.; Zhou J. (2010.): Potentials of phototrophic bacteria in treating pharmaceutical wastewater. International Journal of Environment Science & Technology. 7, 165-174.

 

Maduna Valkaj K.; Katovic A.; Zrncevic S. (2011.): Catalytic properties of Cu/13X zeolite based catalyst in catalytic wet peroxide oxidation of phenol. Industrial Engineering Chemistry and Research,50, 4390–4397.

 

Maduna Valkaj K.; Kaselja I.; Smolkovića J.; Zrnčevića S.; Kumar N.; Murzin D. Yu. (2014.): Catalytic wet peroxide oxidation of olive oil mill wastewater over zeolite based catalyst. Chemical Engineering Transaction, 43, 1-6.

 

Mahamood B.M. (2012.) Degradation kinetics of diclofenac in water by Fenton’s oxidation.Journal of Sustainable Energy & Environment, 3, 173-176.

 

Martínez-Huitle C.A.; Brillas E. (2009.): Decontamination of wastewaters containing synthetic organic dyes by electrochemical methods: a general review. Applied Catalysis B: Environmental, 87, 105-145.

 

Martz M. (2012.): Effective wastewater treatment in the pharmaceutical industry. Pharmaceutical Engineering, 32, 1-12.

 

McArdell C.S.; Molnar E.; Suter M.J.F.; Giger W. (2003.): Occurrence and fate of macrolide antibiotics in wastewater treatment plants and in the Glatt Valley watershed, Switzerland, Environmental Science & Technology, 37, 5479-5486.

 

Melero J. A.; Botas J. A.; Molina R.; Pariente M. I.; Mart F. (2009.): Heterogeneous catalytic wet peroxide oxidation systems for the treatment of an industrial pharmaceutical wastewater.Water Research, 43, 4010−4018.

Miège C.; Choubert J. M.; Ribeiro L.; Eusèbe M.; Coquery M. (2009.): Fate of pharmaceuticals and personal care products in wastewater treatment plants – Conception of a database and first results.Environmental Pollution, 157, 1721-1726.

 

Narvaez J.F.; Jimenez C.C. (2012.): Pharmaceutical products in the environment: Sources, Effects and risks. Vitae, Revista de la Facultad de Quimica Farmaceutica, 19, 93-108

 

Nitesh P.; Kanjan U. (2013.):Treatability study of pharmaceutical wastewater by coagulation process. International Journal of ChemTech Research, 5, 2278-2283.

 

Oetken M.; Nentwig G.; Löffler D.; Ternes T.; Oehlmann J. (2005.): Effects of pharmaceuticals on aquatic invertebrates. Part I. The antiepileptic drug carbamazepine.Archives of Environmental Contamination and Toxicology, 49, 533-561.

 

Odonkor S.T.; Addo K.K. (2011.): Bacteria Resistance to Antibiotics: Recent Trends and Challenges. International Journal of Biological & Medical Research, 2, 1204 – 1210.

 

Okhovat N.; Hashemi M.; Golpayegani A.A. (2015.): Photocatalytic decomposition of Metronidazolein aqueous solutions using titanium dioxide nanoparticles. Journal of Materials and Environmental Science, 6, 792-799.

 

Oreščanin V. (2014.): Procjedne vode odlagališta otpadakemijski sastav, toksični učinci i metode pročišćavanja, Hrvatske vode, 22, 1-12.

 

Otkem Y.A.; Ince O.; Sallis P.; Donnelly T.; Inc e B.K. (2007.): Anaerobic treatment of a chemical synthesisbased pharmaceutical wastewater in hybrid upflow anaerobic sludge blanket reactor. Bioresource Technology, 99, 1089-1096.

 

Patneedi C.B.; Prasadu K.D. (2015.): Impact of pharmaceutical wastes on human life and Environment. Rasayan Journal of Chemistry, 8, 67-70.

 

Penesyan A.; Gillings M.; Paulsen I.T. (2015.): Antibiotic Discovery: Combating Bacterial Resistance in Cells and in Biofilm Communities.Molecules, 20, 5286-5298

 

Peng Y. Z.; Li Y. Z.; Peng C. Y.; Wang S. Y. (2004.): Nitrogen removal from pharmaceutical manufacturing wastewater with high concentration of ammonia and free ammonia via partial nitrification and denitrification. Water Science and Technology, 50, 31−36.

 

Pery A.; Gust M.; Vollat B.; Mons R.; Ramil M.; Fink G.; Ternes T.A.; Garric J. (2008.): Fluoxetine effects assessment on the life cycle of aquatic invertebrates. Chemosphere, 73, 300-304.

 

Pinheiro A.; Albano R.M.R.; Alves T.C.; Kaufmann V.; Rival da Silva M. (2013.): Veterinary antibiotics and hormones in water from application of pig slurry to soil. Agricultural Water Management, 129, 1–8.

 

Priyanka U.; Nandan A. (2014.): Bacterial Dynamics in Antibiotic Wastewater Treatment – A Review. International Journal of Occupational Health & Safety, Fire&Environment, 2, 1-8.

 

Radjenovic J.; Petrovic M.; Barceló D. (2007.): Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor.Analytical and Bioanalytical Chemistry, 387, 1365-1377.

 

Rao A.G.; Naidu G.V.; Prasad K.K.; Rao N.C.; Mohan S.V.; Jetty A.; Sarma P.N. (2004.): Anaerobic treatment of wastewater with high suspended solids from a bulk drug industry using fixed film reactor (AFFR). Bioresource Technology, 93, 241-247.

 

Saleem M. (2007.):Pharmaceutical wastewater treatment: A physicochemical study. Journal of Research (Science), BahauddinZakariyaUniversity, Multan, Pakistan, 18, 125-134.

 

Salgado R.; Marques R.; Noronha J.P.; Carvalho G.; Oehmen A.; Reis M.A.M.(2012.): Assessing the removal of pharmaceuticals and personal care products in a full-scale activated sludge plant. Environmental Science Pollution Research, 19, 1818-1827.

 

Samaras V.G.; Stasinakis A.S.; Mamais D.; Thomaidis N.S.; Lekkas T.D. (2013.): Fate of selected pharmaceuticals and synthetic endocrine disrupting compounds during wastewater treatment and sludge anaerobic digestion. Journal of Hazardous Materials, 244, 245-259.

 

Schäfer A.I.; Akanyeti I.; Semião A.J.C. (2011.): Micropollutant sorption to membrane polymers: A review of mechanisms for estrogens. Advances in Colloid and Interface Science, 164, 100-117.

 

Shaikh I.A.; Ahmed F.; Manzoor-ul-Haq Rajput, Ahmad I.; Amjad R. (2015.): Eco-friendly approach to remove COD, TSS and colour from the effluent originating from the pharmaceutical industry. Pakistan Journal of Nutrition 14, 146-149.

 

Sheldon R.A. (1997.): Catalysis: The key to waste minimization. Journal of Chemical Technology and Biotechnology, 68, 381-388.

 

Sirés I.; Arias C.; Cabot P. L.; Centellas F.; Garrido J. A.; Rodríguez R. M.; Brillas E. (2007.):Degradation of clofibric acid in acidicaqueous medium by electro-Fenton and photoelectro-Fenton. Chemosphere, 66, 1660−1669.

 

Sriprom P.; Neramittagapong S.; Lin C.; Wantala K.; Neramittagapong A.; Grisdanurak N. (2015.): Optimizing chemical oxygen demand removal from synthesized wastewater containing lignin by catalytic wet-air oxidation over CuO/Al2O3 catalysts. Journal of the Air & Waste Management Association, 65, 828-836.

 

Snyder S.; Redding A.; Cannon F.; DeCarolis J.; Oppenheimer J.; Wert E.; Yoon Y. (2007.): Role of membranes and activated carbon in the removal of endocrine disruptors and pharmaceutical. Desalination, 202, 156-181.

 

Sponza D.T.; Ҫelebi H. (2012.): Remuval of oxytetracycline in a synthetic pharmaceutical wastewater by a sequential anaerobic multichamber bed reactors (AMCBR) /completely stirred tank reactor (CSTR) system: Biodegradation and inhibitionkinetics. Bioresource Technology, 104, 100-110.

 

Sreekanth D.; Sivaramakrishna D.; Himabindu V.; Anjaneyulu Y. (2009.): Thermpohilic tratment of bulk drug pharmaceutical industrial wastewater by using hybrid up-flow anaerobic sludge blanket reactor. Bioresource Technology, 100, 2534-2539.

 

Srinivasan P.; Sarmah A.K.; Manley-Harris M. (2014.): Sorption of selected veterinary antibiotics onto dairy farming soils of contrasting nature.Science of the Total Environment, 472, 695-703.

 

Stanley J.K.; Ramirez A.J.; Mottaleb M.; Chambliss C.K.; Brooks B.W. (2006.): Enantiospecific toxicity of the beta-blocker propranolol to Daphnia magna and Pimephales promelas. Environmental Toxicology and Chemistry, 25, 1780-1786.

 

Suárez S.; Lema J.M.; Omil F. (2010.): Removal of pharmaceutical and personal care products (PPCPs) under nitrifying and denitrifying conditions. Water Research, 44, 3214-3224.

 

Sui Q.; Huang J.; Deng S.; Yu G.; Fan Q. (2010.):Occurrence and removal of pharmaceuticals, caffeine and DEET in wastewater treatment plants of Beijing, China. Water Research, 44, 417-426.

 

Sui Q.; Cao X.; Lu S.; Zhao W.; Qiu Z.; Yu G. (2015.): Occurrence, sources and fate of pharmaceuticals and personal care products in the groundwater: A review Emerging Contaminants, 1, 14-24.

 

Sun S.L.; Wu B.; Zhao D.Y.; Zhang X.X.; Zhang Y.; Li W.X.; Cheng S.P. (2009.): Optimization of Xhhh strain biodegradation with metal ions for pharmaceutical wastewater treatment. Journal of Environmental Biology, 30, 877-882.

 

Tekin H.; Bilkay O.; Ataberk S.S.; Balta T.H.; Ceribasi I.H.; Sanin F.D.; Dilek F.B.; Yetis U. (2006.): Use of Fenton oxidation to improve the biodegradability of a pharmaceutical wastewater.Journal of Hazardous Materials, 136, 258-265.

 

Testa B.; Pedretti A.; Vistoli G. (2012.): Reactions and enzymes in the metabolism of drugs and other xenobiotics. Drug Discovery Today, 17, 549-560.

 

Tóth J.E.; Gergely F.; Mizsey P. (2011.): Physiochemical treatment of pharmaceutical wastewater: Distillation and membrane processes. Chemical Engineering, 55, 59-67.

 

Trinh T.; van den Akker B.; Stuetz R.M.; Coleman H.M.; Le-Clech P.; Khan S.J. (2012.): Removal of trace organic chemical contaminants by a membrane bioreactor. Water Science & Technology, 66, 1856-1863.

 

Varatharajan B.; Kanmani S. (2007.): Treatability study of pharmaceutical wastewater by combined sola Photo-fenton and activated sludge process.Journal of Industrial Pollution Control, 23, 157-164.

 

Wei, X.; Li, B.; Zhao, S.; Wang, L.; Zhang, H.; Li, C.; Wang, S. (2012.): Mixed pharmaceutical wastewater treatment by integrated membrane-aerated biofilm reactor. Bioresource Technology, 122, 189-195.

 

Westerhoff P.; Yoon Y.; Snyder S.; Wert E. (2005.): Fate of endocrinedisruptor, pharmaceutical and personal care product chemicals during simulated drinking water process. Environmental Science & Technology, 39, 6449-6663.

 

Zahid F.; Farooq U. (2014.) Removal of active pharmaceutical ingredients from water ba Fentons method.Science International (Lahore),26, 2123-2127.

 

Xin Li.; A Review: Pharmaceutical wastewater treatment technology and research in China, Asia-Pacific Energy Equipment Engineering Research Conference (AP3ER 2015), June 13-14, 2015., Zhuhai, China, 345-348.

 

Yangali-Quintanilla V.; Maeng S.K.; Fujioka T.; Kennedy M.; Li Z.; Amy G. (2011.): Nanofiltration vs. Reverse osmosis for the removal of emerging organic contaminants in water reuse. Desalination and Water Treatment, 34, 50-56.

 

Zhang Y.; Geißen S.U.; Gal C. (2008.): Carbamazepine and diclofenac: Removal in wastewater treatment plants and occurrence in water bodies. Chemosphere, 73, 1151-1161.

 

Zheng W.; Li X.; Hao Z.; Wang D.; Yang Q.; Zeng G. (2010.): Coal cinder filtration as pretreatment with biological processes to treat pharmaceutical wastewater. Water Science & Technology, 62.1,15-20.

 

Zrnčević S. (2008.): Biološko čišćenje voda zagađenih organskim spojevima, Technoeco, 6, 68-71.